Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

M. Raikou; A. McGuire; H. M. Colhoun; D. J. Betteridge; P. N. Durrington; G. A. Hitman; H. A. W. Neil; S. J. Livingstone; V. Charlton-Menys; J. H. Fuller

首页> 外文期刊>Diabetologia >Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

【24h】

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

机译：阿托伐他汀在2型糖尿病中一级预防心血管疾病的成本效益：阿托伐他汀糖尿病合作研究（CARDS）的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study (CARDS).

机译：我们使用协作阿托伐他汀糖尿病研究（CARDS）的数据估算了阿托伐他汀治疗在2型糖尿病患者心血管疾病一级预防中的成本效益。

著录项

来源
《Diabetologia 》 |2007年第4期| 733-740| 共8页
作者
M. Raikou; A. McGuire; H. M. Colhoun; D. J. Betteridge; P. N. Durrington; G. A. Hitman; H. A. W. Neil; S. J. Livingstone; V. Charlton-Menys; J. H. Fuller;
展开▼
作者单位

LSE Health and Social Care London School of Economics and Political Science Houghton Street London WC2A 2AE UK;

LSE Health and Social Care London School of Economics and Political Science Houghton Street London WC2A 2AE UK;

The Conway Institute University College Dublin Ireland;

Department of Medicine The Middlesex Hospital University College London London UK;

Department of Medicine University of Manchester Manchester Royal Infirmary Manchester UK;

Centre for Diabetes and Metabolic Disease Barts and The London Queen Mary’s School of Medicine and Dentistry London UK;

Department of Public Health University of Oxford Oxford UK;

Department of Epidemiology and Public Health Royal Free and University College Medical School London UK;

Department of Medicine University of Manchester Manchester Royal Infirmary Manchester UK;

Department of Epidemiology and Public Health Royal Free and University College Medical School London UK;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Cost-effectiveness; Cardiovascular disease; Statins; Type 2 diabetes;

机译：成本效益;心血管疾病;他汀类药物;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. [J] . Colhoun HM, Betteridge DJ, Durrington PN, The Lancet . 2004 ,第9435期

机译：阿托伐他汀糖尿病合作研究（CARDS）中的阿托伐他汀对2型糖尿病心血管疾病的一级预防：多中心随机安慰剂对照试验。
2. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). [J] . Knopp RH, dEmden M, Smilde JG, Diabetes care . 2006 ,第7期

机译：阿托伐他汀预防2型糖尿病患者心血管终点的功效和安全性：阿托伐他汀预防非胰岛素依赖型糖尿病（ASPEN）冠心病终点的研究。
3. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). [J] . Colhoun HM, Betteridge DJ, Durrington PN American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2009 ,第5期

机译：阿托伐他汀对糖尿病患者肾脏结局和心血管疾病的影响：阿托伐他汀糖尿病合作研究的分析。
4. Application of statins in prevention and treatment of diabetes mellitus with atherosclerotic cardiovascular disease [C] . Li Xiaoxue 2019 International Conference on Biology, Chemistry and Medical Engineering（ 2019年国际生物、化学和医学工程会议（ICBCME 2019）论文集 . -1

机译：他汀类药物在糖尿病患有动脉粥样硬化心血管疾病的预防和治疗中的应用
5. ACE inhibitor therapy for primary prevention of cardiovascular morbidity and mortality in patients with type 2 diabetes. [D] . Eurich, Dean T. 2003

机译：ACE抑制剂疗法可用于一级预防2型糖尿病患者的心血管发病率和死亡率。
6. Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial [O] . Sabita S. Soedamah-Muthu, Shona J. Livingstone, Valentine Charlton-Menys, -1

机译：阿托伐他汀对2型糖尿病患者C反应蛋白的影响及对心血管疾病的益处：阿托伐他汀糖尿病合作研究的分析
7. Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS). [O] . Raikou, M, McGuire, A, Colhoun, HM, 2007

机译：阿托伐他汀在2型糖尿病中一级预防心血管疾病的成本效益：阿托伐他汀糖尿病合作研究的结果。

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

摘要

著录项

相似文献

相关主题

期刊订阅